NB003

· Ningbo Newbay Technology Development Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NB003, covering 2025-12-22 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 2, Phase 3]